Interferon-beta

DBCAT000160Therapeutic category

One of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA. It is a cytokine with antiviral, antiproliferative, and immunomodulating activity. A DrugBank category of 3 drugs. 3 of them are approved.

Also known as: beta 1 Interferon · beta Interferon · beta-1 Interferon · beta-Interferon · Biosyn Brand of Interferon beta
Drugs: Interferon beta-1a
Interferon beta-1b
Peginterferon beta-1a

What you can answer from here — as of August 24, 2016

3DrugsEach linked to its full drug card

Listed above

3Drug targetsEvery drug–target pair in the class, with bond type

157Marketed productsAcross the regions we cover, with dosage forms and routes

5Routes of administrationHow the drugs in this class are given

Which targets do Interferon-beta share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account